Skip to main navigation

Overview
Press Releases
Events & Presentations
Corporate Governance
Financial Information
Stock Information
Shareholder Services

Back to CRISPR »

Presentations

Presentations

Corporate Presentation

CRISPR Therapeutics Q1 2023 Corporate Presentation 4.7 MB

Presentations

Jun 2020

2020 AACR II Virtual Meeting Poster: Allogeneic CAR-T cell products containing 10 gene edits using CRISPR/Cas9 can retain full functionality in vivo and in vitro 522.4 KB

Jun 2020

2020 AACR II Virtual Meeting Poster: Allogeneic anti-PTK7 CAR-T cells for the treatment of solid tumors 628.8 KB

Jun 2020

2020 AACR II Virtual Meeting Poster: Targeting T cell lymphomas with CRISPR/Cas9-generated anti-CD70 allogeneic CAR-T cells 415.8 KB

Jun 2020

2020 European Hematology Association (EHA) Congress Presentation 1.4 MB

May 2020

2020 ASGCT Annual Meeting Poster: Multiplexing of up to 10 gene edits using CRISPR/Cas9 generate CAR-T cells with improved function 621.7 KB

May 2020

2020 ASGCT Annual Meeting Poster: Dual Guide CRISPR/Cas9 Editing of the CCR5 Gene Provides Complete Protection Against HIV in Humanized Mouse Models 249.4 KB

May 2020

2020 ASGCT Annual Meeting Poster: Insertion of Short Double-Stranded Oligonucleotides Using CRISPR/Cas9 as a Therapeutic Approach for Glycogen Storage Disease Type 1a 351 KB

Nov 2019

CRISPR Therapeutics Data Update Call Presentation 817.9 KB

Nov 2019

2019 Annual Meeting of The Society for Immunotherapy of Cancer (SITC) Poster: Single-cell RNA sequencing and functional assessment of healthy donor- and cancer patient-derived T and CAR-T cells 1.1 MB

Sep 2019

2019 European Association for the Study of Diabetes (EASD) Presentation 1.3 MB

Pagination

First page
Previous page
Page 1
Page 2
Current page 3
Page 4
Next page
Last page

Displaying 21 - 30 of 38

Shareholder Tools

Print Page
RSS Feeds
Email Alerts
Contact IR

Interested in joining our team? Careers at CRISPR

© 2023 CRISPR Therapeutics. Contact | Privacy Policy | Terms and Conditions